HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematopoietic stem cell transplantation for classical inherited bone marrow failure syndromes: an update.

AbstractINTRODUCTION:
Inherited bone marrow failure syndromes (IBMFS) feature complex molecular pathophysiology resulting in ineffective hematopoiesis and increased risk of progression to myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Allogenic hematopoietic stem cell transplantation (HSCT) is the only well-established cure for the hematological manifestations of these diseases.
AREAS COVERED:
In recent years, analysis of large series from international databases (mainly from the European Bone Marrow Transplantation [EBMT] database) has improved knowledge about HSCT in IBMFS. This review, following a thorough Medline search of the pertinent published studies, reports the most recent data on HSCT in IBMFS.
EXPERT OPINION:
Despite the common features, IBMFS are very different in their manifestations and in the occurrence and management of HSCT complications. Thus, a 'disease-specific' HSCT using an optimized conditioning regimen based on the characteristics of the disease is essential for achieving long-term survival. The phenotypical heterogeneity associated with extramedullary abnormalities has to be carefully evaluated before HSCT because transplantation may only correct impaired hematopoiesis. HSCT may be associated with the risk of treatment-related mortality and with significant early and late morbidity. For these reasons, the benefits should be carefully weighed against the risks.
AuthorsFilomena Pierri, Maura Faraci, Stefano Giardino, Carlo Dufour
JournalExpert review of hematology (Expert Rev Hematol) Vol. 14 Issue 10 Pg. 911-925 (10 2021) ISSN: 1747-4094 [Electronic] England
PMID34488529 (Publication Type: Journal Article, Review)
Topics
  • Congenital Bone Marrow Failure Syndromes
  • Hematopoietic Stem Cell Transplantation (adverse effects, methods)
  • Humans
  • Leukemia, Myeloid, Acute (etiology)
  • Myelodysplastic Syndromes (genetics, therapy)
  • Transplantation Conditioning (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: